Wound Care Biologics Global Market Report 2024 | Size, Share, Growth, Trends, Analysis, Forecast, Outlook, Mergers and Acquisitions, Top Major Key Players | 2033 Forecast

The wound care biologics market size has grown strongly in recent years. It will grow from $1.76 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to clinical evidence and studies, regulatory framework development, wound care market evolution, limited treatment options, research and development efforts.

The wound care biologics market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to focus on personalized medicine, rise in healthcare expenditure, value-based healthcare models, growing demand for advanced therapies, regulatory support and approvals. Major trends in the forecast period include regenerative medicine emphasis, bioengineered skin substitutes, innovative delivery systems, rise in chronic wound management, patient-centric care.

Market Overview -
Wound care biologics are bioengineered products used for non-healing wounds of the lower extremity. These biologics are gaining recognition in wound care because they effectively control secretions and protect against bacterial infection.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10584&type=smp

Rising Prevalence Of Diabetes To Drive Market Growth
The high prevalence of diabetes is expected to propel the growth of the wound care biologics market in the coming future. diabetes is a chronic metabolic condition characterized by high levels of blood glucose (or blood sugar), which causes catastrophic damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Biological wound care prevents volatile water loss, heat loss, protein and electrolyte loss, and contamination. They also allow autolytic debridement and produce a granular wound layer. The high prevalence of diabetes is one of the factors driving the growth of the wound care biologics market. For instance, in December 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, 537 million persons (20-79 years old) were estimated to have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. Therefore, the high prevalence of diabetes is driving the wound care biologics market.

Competitive Landscape -
Major companies operating in the wound care biologics market report are Integra Lifesciences Corporation, Organogenesis Inc., Smith and Nephew plc, Wright Medical Group NV, MiMedx Group Inc., Kerecis AG, Amnio Technology LLC, Anika Therapeutics Inc., ACell Inc., Derma Sciences Inc., Soluble Systems Pvt. Ltd., Medline Industries LP, Solsys Medical LLC, Zimmer Biomet Holdings Inc., MLM Biologics Inc., Tissue Genesis LLC, Stryker Corporation, Marine Polymer Technologies Inc., Bioventus Inc., Mölnlycke Health Care AB, Lynch Biologics LLC, Skye Biologics Holdings LLC, Osiris Therapeutics Inc., Vericel Corporation, TissueTech Inc., PolarityTE Inc., Avita Medical Limited, Celularity Inc., Human Regenerative Technologies LLC, PolyRemedy Inc.

Product Innovations Transforming The Wound Care Biologics Market
Product innovation is a key trend gaining popularity in the consumer and wound care biologics market. Major companies operating in the wound care biologics market are focused on developing innovative products with advanced technologies to strengthen their position in the market. For instance, in April 2021, Kerecis, a US-based company used to treat wounds, burns, and other complex acute and chronic wounds, launched its Kerecis Omega3 GraftGuide. This fish skin is whole and specifically addresses the difficulties of burn healing. The product improves autograft take, lessens the need for autograft harvesting, and even serves as an alternative to autografting. The FDA approves it under the 510(k) regulatory procedure.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/wound-care-biologics-global-market-report

Key Segments -
The wound care biologics market covered in this report is segmented -
1) By Product: Biologic Skin Substitutes, Topical Agents
2) By Wound Type: Ulcers, Surgical, Traumatic Wounds, Burns
3) By End User: Hospitals, Ambulatory Surgery Center (ACS), Burn Centers, Wound Clinics

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.